Yearly Archives: 2024

/2024

Pharmacy First: To reject or not to reject?

LPCs across Cheshire and Merseyside have been reviewing Pharmacy First data and have identified several referrals from GP practices where a pharmacy has rejected a referral where a Minor illness consultation could have been completed and claimed. The data also showed examples of where the rejection message showed that a consultation had taken place, but [...]

The post Pharmacy First: To reject or not to reject? appeared first on Community Pharmacy England.

By |June 18th, 2024|Lexpos News|Comments Off on Pharmacy First: To reject or not to reject?

Pharmacy First: CPPE launches Common clinical conditions e-learning

The Centre for Pharmacy Postgraduate Education (CPPE) has launched a Common clinical conditions e-learning programme. This e-learning programme is designed to help update pharmacy professionals’ knowledge and skills to help with the management of common clinical conditions and minor ailments that may present themselves in community pharmacy. The programme contains practical tips and advice on [...]

The post Pharmacy First: CPPE launches Common clinical conditions e-learning appeared first on Community Pharmacy England.

By |June 18th, 2024|Lexpos News|Comments Off on Pharmacy First: CPPE launches Common clinical conditions e-learning

MHRA Class 4 Medicines Defect Information: Oxcarbazepine Mylan 150 mg, 300mg, 600mg Film-Coated Tablets (Mylan)

Class 4 Medicines Defect Information: Oxcarbazepine Mylan 150 mg, 300mg, 600mg Film-Coated Tablets (Mylan) Drug alert number: EL (24)A/22 Date issued: 17 June 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Oxcarbazepine Mylan 150 mg, 300mg, 600mg Film-Coated Tablets (Mylan) Company name: Viatris UK Healthcare [...]

The post MHRA Class 4 Medicines Defect Information: Oxcarbazepine Mylan 150 mg, 300mg, 600mg Film-Coated Tablets (Mylan) appeared first on Community Pharmacy England.

By |June 17th, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Oxcarbazepine Mylan 150 mg, 300mg, 600mg Film-Coated Tablets (Mylan)

10 days left to submit EOI for autumn/winter C-19 vacs service

Pharmacy owners have 10 days left to submit an expression of interest (EOI) if they wish to take part in this autumn/winter’s COVID-19 vaccination service, as the interim response deadline for submissions is 11.59pm on 27th June 2024. Further information on the EOI process and provision of the service can be found in our news story highlighting the [...]

The post 10 days left to submit EOI for autumn/winter C-19 vacs service appeared first on Community Pharmacy England.

By |June 17th, 2024|Lexpos News|Comments Off on 10 days left to submit EOI for autumn/winter C-19 vacs service

Our response to Labour Party Manifesto

Community Pharmacy England has issued the following statement in response to the Labour Party Manifesto. Our CEO Janet Morrison said: “We have been urging all political parties to commit to working with us to make better use of the skills of community pharmacists for the benefit of patients, pharmacies and the wider NHS. Pharmacies have [...]

The post Our response to Labour Party Manifesto appeared first on Community Pharmacy England.

By |June 13th, 2024|Lexpos News|Comments Off on Our response to Labour Party Manifesto